(Reuters) – Medical device maker Quest Diagnostics Inc posted a 373.7% rise in first-quarter profit on Thursday, boosted by a faster-than-expected recovery of its non-COVID-19-related businesses.
Net income attributable to the company rose to $469 million, or $3.46 per share, in the quarter ended March 31, from $99 million, or 73 cents per share, a year earlier.
Revenue increased to $2.72 billion from $1.82 billion.
(Reporting by Trisha Roy in Bengaluru; Editing by Amy Caren Daniel)
